DRUG · Mapped RxNorm record
Bicalutamide
Normalized identity: bicalutamideView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer
NCT07593079
Drugs and interventions used in this trial
4 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DEVICE · Unmapped registry intervention
Prostate-specific membrane antigen Positron Emission Tomography-Computed Tomography
Find medicine records ·
Find other trials using this name
DRUG · Unmapped registry intervention
18F-rhPSMA-7.3
Find medicine records ·
Find other trials using this name
DIAGNOSTIC_TEST · Unmapped registry intervention
PROSTest
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedProstate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate Cancer
Design: INTERVENTIONAL · Status: NOT YET RECRUITING · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Recurrent Prostate Cancerunresolved
Prostate Cancer Recurrentunresolved
Interventions
Sponsors & collaborators
Washington University School of Medicinelead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07593079 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.